Skip to NavigationSkip to content


Bayer and GlaxoSmithKline's new erectile dysfunction treatment Levitra has been launched in the UK, its first market after receiving European...
A chronic shortage of staff in some parts of the NHS is holding back improvements to the service, according to a major new report.
Bristol-Myers Squibb is attempting to draw a line under allegations of fraud and financial misconduct by downgrading earnings as far back as 1999.
Continuing conflict over access to medicines in developing countries and growing distrust of big pharma in domestic markets is threatening to...
AstraZeneca's cholesterol treatment Crestor has been dealt a serious blow following Germany's withdrawal from a pan-European approval process.
Health Secretary Alan Milburn has published the final plans for the controversial foundation trusts with the promise that all NHS hospitals could...
Vaccine company Acambis has joined rivals PowderJect and Celltech in the elite group of profitable UK biotech companies.
Matthew Emmens, former head of Merck KGaA's global prescription group, has been appointed as the new Chief Executive of Shire Pharmaceuticals.
Plans to make clinical trials mandatory for all drugs intended for children are progressing in the US.
GlaxoSmithKline has increased its predicted earnings for 2003 despite a virtually unchanged turnover in the second quarter.
Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches